Skip to main content

Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells

Project Member(s): Simpson, A.

Funding or Partner Organisation: Pharmacyte Biotech Inc

Start year: 2015

Summary: This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.

Keywords: Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson

FOR Codes: Clinical Sciences, Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes, Regenerative medicine (incl. stem cells), Clinical health